Tasly Pharmaceutical Group Co Ltd (600535) — Net Asset Quality Index
Tasly Pharmaceutical Group Co Ltd (600535) has a Net Asset Quality Index of 86.3% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥15.30 Billion minus total liabilities of CN¥2.09 Billion yields net assets of CN¥13.21 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Read Tasly Pharmaceutical Group Co Ltd (600535) financial obligations for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Tasly Pharmaceutical Group Co Ltd Net Asset Quality Index Over Time (1999–2025)
This chart shows how Tasly Pharmaceutical Group Co Ltd's Net Asset Quality Index has evolved across 27 annual periods from 1999 to 2025. As of June 2026, the index stands at 86.3%, representing net assets of CN¥13.21 Billion against total assets of CN¥15.30 Billion CNY. For live market cap and overall valuation, see 600535 stock market capitalisation.
Annual Net Asset Quality Index for Tasly Pharmaceutical Group Co Ltd (1999–2025)
The table below presents the year-by-year Net Asset Quality Index for Tasly Pharmaceutical Group Co Ltd from 1999 to 2025, covering 27 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check 600535 strategic asset allocation to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 81.8% | CN¥12.55 Billion | CN¥15.34 Billion | CN¥2.79 Billion | ▲ +0.9 pp |
| 2024 | 80.9% | CN¥12.11 Billion | CN¥14.98 Billion | CN¥2.87 Billion | ▲ +4.9 pp |
| 2023 | 75.9% | CN¥12.69 Billion | CN¥16.71 Billion | CN¥4.02 Billion | ▼ -1.0 pp |
| 2022 | 76.9% | CN¥12.63 Billion | CN¥16.43 Billion | CN¥3.80 Billion | ▼ -3.6 pp |
| 2021 | 80.5% | CN¥13.31 Billion | CN¥16.54 Billion | CN¥3.23 Billion | ▲ +5.4 pp |
| 2020 | 75.1% | CN¥12.38 Billion | CN¥16.49 Billion | CN¥4.11 Billion | ▲ +25.7 pp |
| 2019 | 49.4% | CN¥11.86 Billion | CN¥24.01 Billion | CN¥12.15 Billion | ▲ +4.9 pp |
| 2018 | 44.5% | CN¥11.21 Billion | CN¥25.17 Billion | CN¥13.96 Billion | ▲ +2.8 pp |
| 2017 | 41.7% | CN¥8.97 Billion | CN¥21.53 Billion | CN¥12.56 Billion | ▼ -6.2 pp |
| 2016 | 47.9% | CN¥8.21 Billion | CN¥17.13 Billion | CN¥8.92 Billion | ▼ -2.1 pp |
| 2015 | 50.0% | CN¥7.71 Billion | CN¥15.41 Billion | CN¥7.71 Billion | ▲ +10.8 pp |
| 2014 | 39.2% | CN¥5.07 Billion | CN¥12.92 Billion | CN¥7.85 Billion | ▼ -1.3 pp |
| 2013 | 40.6% | CN¥4.14 Billion | CN¥10.21 Billion | CN¥6.07 Billion | ▼ -15.6 pp |
| 2012 | 56.2% | CN¥4.21 Billion | CN¥7.49 Billion | CN¥3.28 Billion | ▼ -0.7 pp |
| 2011 | 56.9% | CN¥3.78 Billion | CN¥6.63 Billion | CN¥2.86 Billion | ▼ -5.9 pp |
| 2010 | 62.8% | CN¥3.42 Billion | CN¥5.45 Billion | CN¥2.03 Billion | ▲ +8.9 pp |
| 2009 | 53.9% | CN¥2.17 Billion | CN¥4.03 Billion | CN¥1.85 Billion | ▼ -6.8 pp |
| 2008 | 60.7% | CN¥2.09 Billion | CN¥3.45 Billion | CN¥1.36 Billion | ▼ -3.1 pp |
| 2007 | 63.8% | CN¥1.97 Billion | CN¥3.09 Billion | CN¥1.12 Billion | ▲ +11.1 pp |
| 2006 | 52.8% | CN¥1.72 Billion | CN¥3.26 Billion | CN¥1.54 Billion | ▼ -4.0 pp |
| 2005 | 56.8% | CN¥1.56 Billion | CN¥2.75 Billion | CN¥1.19 Billion | ▼ -5.6 pp |
| 2004 | 62.5% | CN¥1.37 Billion | CN¥2.20 Billion | CN¥826.42 Million | ▼ -5.2 pp |
| 2003 | 67.6% | CN¥1.20 Billion | CN¥1.78 Billion | CN¥575.74 Million | ▼ -12.1 pp |
| 2002 | 79.7% | CN¥997.00 Million | CN¥1.25 Billion | CN¥253.70 Million | ▲ +38.2 pp |
| 2001 | 41.5% | CN¥247.20 Million | CN¥595.39 Million | CN¥348.19 Million | ▲ +4.3 pp |
| 2000 | 37.2% | CN¥156.32 Million | CN¥420.47 Million | CN¥264.15 Million | ▼ -1.4 pp |
| 1999 | 38.5% | CN¥135.05 Million | CN¥350.34 Million | CN¥215.29 Million | — |